Form 4: Twist Bioscience Chief Accounting Officer Sells Shares to Cover Tax Obligations

Twist Bioscience's Chief Accounting Officer, Robert F. Werner, sold 789 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Robert F. Werner, Chief Accounting Officer of Twist Bioscience, sold 789 shares of common stock on November 25, 2024.
• The sale was executed at a price of $44.196 per share.
• This transaction was not a discretionary trade but rather a 'sell to cover' transaction mandated by the company to satisfy tax withholding obligations related to the vesting of restricted stock units.
• Following the transaction, Werner directly owns 44,831 shares of Twist Bioscience common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of positive or negative sentiment.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.

Comparison to Industry Standards

• Many companies use 'sell to cover' mechanisms to manage tax obligations for employees receiving equity compensation.
• The sale of shares by an officer to cover taxes is a standard practice and does not necessarily indicate a change in the officer's outlook on the company's future.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Twist Bioscience, Robert F. Werner, stock sale, insider trading, tax obligations, restricted stock units, sell to cover, equity compensation